Lopes, R. D., Al-Khatib, S., Wallentin, L., Yang, H., Ansell, J., Easton, J. D., … Alexander, J. (2012). EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. In Journal of the American College of Cardiology (Vol. 59, pp. E574–E574). Elsevier BV. https://doi.org/10.1016/s0735-1097(12)60575-0

Lopes, Renato D., Sana Al-Khatib, Lars Wallentin, Hongqiu Yang, Jack Ansell, J Donald Easton, Cetin Erol, et al. “EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION.” In Journal of the American College of Cardiology, 59:E574–E574. Elsevier BV, 2012. https://doi.org/10.1016/s0735-1097(12)60575-0.

Lopes RD, Al-Khatib S, Wallentin L, Yang H, Ansell J, Easton JD, et al. EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. In: Journal of the American College of Cardiology. Elsevier BV; 2012. p. E574–E574.

Lopes, Renato D., et al. “EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION.” Journal of the American College of Cardiology, vol. 59, no. 13, Elsevier BV, 2012, pp. E574–E574. Crossref, doi:10.1016/s0735-1097(12)60575-0.

Lopes RD, Al-Khatib S, Wallentin L, Yang H, Ansell J, Easton JD, Erol C, Ezekowitz J, Gersh B, Hohnloser S, Hylek E, Bahit C, Horowitz J, Caterina RD, Mohan P, Vinereanu D, Granger C, Alexander J. EFFICACY AND SAFETY OF APIXABAN COMPARED WITH WARFARIN ACCORDING TO CHADS2 AND HASBLED RISK SCORES FOR STROKE PREVENTION IN ATRIAL FIBRILLATION. Journal of the American College of Cardiology. Elsevier BV; 2012. p. E574–E574.